1. Home
  2. CLMT vs GPCR Comparison

CLMT vs GPCR Comparison

Compare CLMT & GPCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLMT
  • GPCR
  • Stock Information
  • Founded
  • CLMT 1916
  • GPCR 2016
  • Country
  • CLMT United States
  • GPCR United States
  • Employees
  • CLMT N/A
  • GPCR N/A
  • Industry
  • CLMT Oil & Gas Production
  • GPCR
  • Sector
  • CLMT Energy
  • GPCR
  • Exchange
  • CLMT Nasdaq
  • GPCR Nasdaq
  • Market Cap
  • CLMT 1.3B
  • GPCR 1.1B
  • IPO Year
  • CLMT 2006
  • GPCR 2023
  • Fundamental
  • Price
  • CLMT $16.13
  • GPCR $17.83
  • Analyst Decision
  • CLMT Strong Buy
  • GPCR Strong Buy
  • Analyst Count
  • CLMT 6
  • GPCR 7
  • Target Price
  • CLMT $20.17
  • GPCR $76.17
  • AVG Volume (30 Days)
  • CLMT 754.4K
  • GPCR 703.8K
  • Earning Date
  • CLMT 08-08-2025
  • GPCR 08-11-2025
  • Dividend Yield
  • CLMT N/A
  • GPCR N/A
  • EPS Growth
  • CLMT N/A
  • GPCR N/A
  • EPS
  • CLMT N/A
  • GPCR N/A
  • Revenue
  • CLMT $4,177,500,000.00
  • GPCR N/A
  • Revenue This Year
  • CLMT N/A
  • GPCR N/A
  • Revenue Next Year
  • CLMT N/A
  • GPCR N/A
  • P/E Ratio
  • CLMT N/A
  • GPCR N/A
  • Revenue Growth
  • CLMT 0.68
  • GPCR N/A
  • 52 Week Low
  • CLMT $7.68
  • GPCR $13.22
  • 52 Week High
  • CLMT $25.29
  • GPCR $45.37
  • Technical
  • Relative Strength Index (RSI)
  • CLMT 49.53
  • GPCR 33.30
  • Support Level
  • CLMT $15.40
  • GPCR $17.45
  • Resistance Level
  • CLMT $17.29
  • GPCR $18.78
  • Average True Range (ATR)
  • CLMT 0.69
  • GPCR 0.89
  • MACD
  • CLMT -0.11
  • GPCR -0.01
  • Stochastic Oscillator
  • CLMT 38.62
  • GPCR 13.57

About CLMT Calumet Specialty Products Partners L.P. Common Units

Calumet Inc is a producer of specialty products, including base oils, specialty oils, solvents, esters, and waxes, as well as a variety of fuel and fuel-related products, including asphalt and heavy fuel oils. The company manufactures, formulates, and markets a variety of specialty branded products to customers in various consumer-facing and industrial markets. Its segments include: Specialty Products and Solutions; Montana/Renewables; Performance Brands; and Corporate. The company generates maximum revenue from Fuels, asphalt and other by-products.

About GPCR Structure Therapeutics Inc.

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.

Share on Social Networks: